ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 77 filers reported holding ONCOCYTE CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,133,755 | -37.6% | 13,625,022 | -3.8% | 0.42% | -18.3% |
Q1 2023 | $5,020,488 | -13.4% | 14,166,163 | -21.5% | 0.51% | +69.9% |
Q4 2022 | $5,794,258 | -56.0% | 18,056,274 | 0.0% | 0.30% | -60.8% |
Q3 2022 | $13,181,000 | -18.9% | 18,056,274 | 0.0% | 0.76% | -19.1% |
Q2 2022 | $16,245,000 | -10.8% | 18,056,274 | +47.7% | 0.94% | +59.6% |
Q1 2022 | $18,214,000 | -31.3% | 12,223,953 | 0.0% | 0.59% | -38.5% |
Q4 2021 | $26,526,000 | -39.0% | 12,223,953 | 0.0% | 0.96% | -27.4% |
Q3 2021 | $43,517,000 | -38.0% | 12,223,953 | 0.0% | 1.32% | -39.4% |
Q2 2021 | $70,165,000 | +10.6% | 12,223,953 | 0.0% | 2.18% | +20.8% |
Q1 2021 | $63,442,000 | +322.5% | 12,223,953 | +94.6% | 1.81% | +231.1% |
Q4 2020 | $15,016,000 | +79.4% | 6,282,823 | +4.3% | 0.55% | +26.7% |
Q3 2020 | $8,371,000 | -26.8% | 6,022,534 | +0.6% | 0.43% | -60.8% |
Q2 2020 | $11,429,000 | -16.4% | 5,983,724 | +7.3% | 1.10% | -32.3% |
Q1 2020 | $13,667,000 | +6.6% | 5,578,283 | -2.1% | 1.62% | +43.9% |
Q4 2019 | $12,817,000 | – | 5,696,576 | – | 1.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 17,349,945 | $61,766,000 | 3.15% |
Defender Capital, LLC. | 1,960,820 | $6,935,000 | 2.26% |
Millrace Asset Group, Inc. | 613,885 | $2,185,000 | 1.36% |
PURA VIDA INVESTMENTS, LLC | 12,223,953 | $43,517,000 | 1.32% |
Penbrook Management LLC | 577,200 | $2,055,000 | 1.28% |
ACT CAPITAL MANAGEMENT, LLC | 330,000 | $1,175,000 | 0.61% |
AWM Investment Company, Inc. | 717,000 | $2,553,000 | 0.25% |
Colonial River Wealth Management, LLC | 66,200 | $218,000 | 0.15% |
CALIBER WEALTH MANAGEMENT, LLC | 66,200 | $218,000 | 0.15% |
Fort Sheridan Advisors LLC | 110,000 | $392,000 | 0.13% |